Literature DB >> 10854430

Determinants of vitellogenin B1 promoter architecture. HNF3 and estrogen responsive transcription within chromatin.

D Robyr1, A Gegonne, A P Wolffe, W Wahli.   

Abstract

The liver-specific vitellogenin B1 promoter is efficiently activated by estrogen within a nucleosomal environment after microinjection into Xenopus laevis oocytes, consistent with the hypothesis that significant nucleosome remodeling over this promoter is not a prerequisite for the activation by the estrogen receptor (ERalpha). This observation lead us to investigate determinants other than ERalpha of chromatin structure and transcriptional activation of the vitellogenin B1 promoter in this system and in vitro. We find that the liver-enriched transcription factor HNF3 has an important organizational role for chromatin structure as demonstrated by DNase I-hypersensitive site mapping. Both HNF3 and the estrogen receptor activate transcription synergistically and are able to interact with chromatin reconstituted in vitro with three positioned nucleosomes. We propose that HNF3 is the cellular determinant which establishes a promoter environment favorable to a rapid transcriptional activation by the estrogen receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854430     DOI: 10.1074/jbc.M002726200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Chromosomal elements regulate gene activity and chromatin structure of the human serpin gene cluster at 14q32.1.

Authors:  Mark D Marsden; R E K Fournier
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

Authors:  Josée Laganière; Geneviève Deblois; Céline Lefebvre; Alain R Bataille; François Robert; Vincent Giguère
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

Review 3.  FOXA1: a transcription factor with parallel functions in development and cancer.

Authors:  Gina M Bernardo; Ruth A Keri
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

4.  TAFII55 binding to TAFII250 inhibits its acetyltransferase activity.

Authors:  A Gegonne; J D Weissman; D S Singer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  Functional analysis of p53 binding under differential stresses.

Authors:  Adam J Krieg; Ester M Hammond; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

6.  Predicting the clinical status of human breast cancer by using gene expression profiles.

Authors:  M West; C Blanchette; H Dressman; E Huang; S Ishida; R Spang; H Zuzan; J A Olson; J R Marks; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease.

Authors:  Graciliano R A do Nascimento; Yaskara V R Barros; Amanda K Wells; Raouf A Khalil
Journal:  Curr Hypertens Rev       Date:  2009-11

Review 8.  Chromatin remodeling by nuclear receptors.

Authors:  Pratibha B Hebbar; Trevor K Archer
Journal:  Chromosoma       Date:  2003-02-26       Impact factor: 4.316

Review 9.  Feed-forward transcriptional programming by nuclear receptors: regulatory principles and therapeutic implications.

Authors:  Sarah K Sasse; Anthony N Gerber
Journal:  Pharmacol Ther       Date:  2014-08-25       Impact factor: 12.310

10.  FOXA1 mutations in hormone-dependent cancers.

Authors:  Jessica L L Robinson; Kelly A Holmes; Jason S Carroll
Journal:  Front Oncol       Date:  2013-02-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.